Tapewire

Nasdaq · USD

UTHR

UNITED THERAPEUTICS Corp

Export transactions ↓
Tapewire entity
664
SEC CIK
0001082554
Parsed reports
1,261

Last 12 months

Inside the activity.

1 purchase rows · 2632 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250142
Dec 20250143
Jan 2026078
Feb 2026026
Mar 20260364
Apr 20260346
May 20261340
Jun 20260298
Jul 20260240
Aug 20260251
Sep 20260260
Oct 20260144

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 10, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 13,800 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · derivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 338,669

Underlying: Common Stock · 13,800 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 9,940 $237.52 $2,360,936.87
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,291 $237.68 $306,846.30
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,070

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $237.45 to $237.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,732 $236.73 $410,015.49
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,361

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $236.38 to $237.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 527 $235.69 $124,206.26
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,093

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $235.19 to $236.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 102 $234.26 $23,894.11
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,620

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $234.055 to $234.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 208 $233.09 $48,481.80
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,722

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $232.735 to $233.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 13,800 $129.49 $1,786,962.00
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,930

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 09, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · derivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 352,469

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 09, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 8,006 $237.52 $1,901,562.70
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $237.10 to $238.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 09, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 6,994 $236.74 $1,655,793.13
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,136

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $236.09 to $237.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 09, 2024 Filed Apr 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-010689 · form4-04112024_040401.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
DWEK RAYMONDDirector
Exercise / conversionShare Tracking Award · Derivative 4,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-24-010572 · form4-04092024_040405.xml · derivative · entry 3

DWEK RAYMOND · CIK 0001231617 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 4,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
DWEK RAYMONDDirector
Disposition to issuerCommon Stock 4,000 $236.96 $947,840.00
Disclosure

SEC source: 0001415889-24-010572 · form4-04092024_040405.xml · nonDerivative · entry 2

DWEK RAYMOND · CIK 0001231617 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,750

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
DWEK RAYMONDDirector
Exercise / conversionCommon Stock 4,000 $88.03 $352,120.00
Disclosure

SEC source: 0001415889-24-010572 · form4-04092024_040405.xml · nonDerivative · entry 1

DWEK RAYMOND · CIK 0001231617 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 5,060 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · derivative · entry 16

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 367,469

Underlying: Common Stock · 5,060 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 113 $239.63 $27,078.19
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 14

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,732 $238.85 $413,694.09
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 243

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F12 · price: This transaction was executed in multiple trades at prices ranging from $238.325 to $239.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,114 $237.63 $264,722.16
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,975

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F11 · price: This transaction was executed in multiple trades at prices ranging from $237.19 to $238.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,639 $236.86 $388,206.66
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,089

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F10 · price: This transaction was executed in multiple trades at prices ranging from $236.19 to $237.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 260 $235.36 $61,192.82
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,728

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F9 · price: This transaction was executed in multiple trades at prices ranging from $235.03 to $235.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 202 $232.43 $46,951.47
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,988

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $232.04 to $232.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 08, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 5,060 $129.49 $655,219.40
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · derivative · entry 15

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 372,529

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,405 $236.91 $569,758.69
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $236.57 to $237.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 4,667 $235.91 $1,100,981.24
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,535

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $235.39 to $236.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,986 $234.74 $700,946.78
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,202

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $234.21 to $235.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 4,176 $233.77 $976,213.50
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,188

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $233.20 to $234.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 562 $232.75 $130,803.53
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,364

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $232.16 to $233.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 204 $231.31 $47,186.57
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,926

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $231.14 to $231.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 05, 2024 Filed Apr 9, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-010571 · form4-04092024_040402.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 04, 2024 Filed Apr 4, 2024 20:30 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
Exercise / conversionStock Options · Derivative 6,000 $0.00 Strike: $117.76 $0.00
Disclosure

SEC source: 0001415889-24-010279 · form4-04042024_040401.xml · derivative · entry 7

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,000

Underlying: Common Stock · 6,000 shares

Expires 2027-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

Read SEC document
April 04, 2024 Filed Apr 4, 2024 20:30 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 206 $234.09 $48,222.31
Disclosure

SEC source: 0001415889-24-010279 · form4-04042024_040401.xml · nonDerivative · entry 6

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,710

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F6 · price: This transaction was executed in multiple trades at prices ranging from $234.08 to $234.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 4, 2024 20:30 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 1,041 $233.64 $243,221.22
Disclosure

SEC source: 0001415889-24-010279 · form4-04042024_040401.xml · nonDerivative · entry 5

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,916

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $233.00 to $233.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 4, 2024 20:30 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 3,279 $232.55 $762,538.34
Disclosure

SEC source: 0001415889-24-010279 · form4-04042024_040401.xml · nonDerivative · entry 4

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,957

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $231.96 to $232.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 4, 2024 20:30 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 1,374 $230.99 $317,382.18
Disclosure

SEC source: 0001415889-24-010279 · form4-04042024_040401.xml · nonDerivative · entry 3

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,236

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $230.65 to $231.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 4, 2024 20:30 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 100 $228.84 $22,884.20
Disclosure

SEC source: 0001415889-24-010279 · form4-04042024_040401.xml · nonDerivative · entry 2

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,610

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $228.56 to $229.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 4, 2024 20:30 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
Exercise / conversionCommon Stock 6,000 $117.76 $706,560.00
Disclosure

SEC source: 0001415889-24-010279 · form4-04042024_040401.xml · nonDerivative · entry 1

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

Read SEC document
April 04, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · derivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 387,529

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 04, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 666 $234.63 $156,263.71
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F10 · price: This transaction was executed in multiple trades at prices ranging from $234.35 to $234.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 7,478 $233.88 $1,748,958.38
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 796

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F9 · price: This transaction was executed in multiple trades at prices ranging from $233.29 to $234.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 5,323 $232.84 $1,239,422.22
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,274

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $232.25 to $233.235. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,025 $231.47 $237,261.67
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,597

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $231.11 to $232.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 508 $230.65 $117,168.52
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,622

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $230.075 to $230.995. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 04, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · derivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 402,529

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 3,057 $231.69 $708,282.44
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $231.44 to $232.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 8,039 $230.97 $1,856,801.59
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,187

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $230.44 to $231.395. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 3,181 $230.05 $731,797.32
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,226

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $229.41 to $230.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 723 $223.73 $161,753.61
Disclosure

SEC source: 0001415889-24-010412 · form4-04052024_040421.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,407

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $228.345 to $229.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.